Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy
出版年份 2010 全文链接
标题
Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy
作者
关键词
-
出版物
CELL CYCLE
Volume 9, Issue 9, Pages 1839-1846
出版商
Informa UK Limited
发表日期
2010-05-21
DOI
10.4161/cc.9.9.11544
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation
- (2014) Ramiro París et al. CELL CYCLE
- BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death
- (2011) Mark Wade et al. CELL CYCLE
- The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors
- (2011) Martin G. Belinsky et al. CELL CYCLE
- Stem cell aging: Survival of the laziest?
- (2011) Christa Muller-Sieburg et al. CELL CYCLE
- Phosphoinositide 3-kinase signaling overrides a G2phase arrest checkpoint and promotes aberrant cell cycling and death of hematopoietic cells after DNA damage
- (2011) Dipali Nimbalkar et al. CELL CYCLE
- Cancer stem cells and survival pathways
- (2011) Dolores Hambardzumyan et al. CELL CYCLE
- Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
- (2011) Ana R. Gomes et al. CELL CYCLE
- Cancer and aging: More puzzles, more promises?
- (2011) Mikhail V Blagosklonny et al. CELL CYCLE
- Cancer stem cells: Models, mechanisms and implications for improved treatment
- (2011) Jiangbing Zhou et al. CELL CYCLE
- Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors
- (2011) Arkaitz Carracedo et al. CELL CYCLE
- Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation
- (2011) Mingxuan Xia et al. CELL CYCLE
- The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia
- (2011) Teresa Palomero et al. CELL CYCLE
- Perspective: Expanding role of cyclin dependent kinases in cytokine inducible gene expression
- (2011) Allan R. Brasier CELL CYCLE
- The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior
- (2011) Yan Liu et al. CELL CYCLE
- Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: Implications for drug resistance and in vitro drug screening models
- (2011) Michal Sabisz et al. CELL CYCLE
- DNA damage-induced cell death is enhanced by progression through mitosis
- (2011) Hanne Varmark et al. CELL CYCLE
- p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells
- (2011) Shivashni S. Gaundar et al. CELL CYCLE
- Mutant p53 rescue and modulation of p53 redox state
- (2011) Vladimir J.N. Bykov et al. CELL CYCLE
- Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- The transcription-independent mitochondrial p53 program is a major contributor to Nutlin-induced apoptosis in tumor cells
- (2011) Angelina V. Vaseva et al. CELL CYCLE
- Stem-cell driven cancer: "Hands-off" regulation of cancer development
- (2011) Carolina Vicente-Dueñas et al. CELL CYCLE
- Upregulation of the CDC25A phosphatase downstream of the NPM/ALK oncogene participates in anaplastic large cell lymphoma enhanced proliferation
- (2011) Anne Fernandez-Vidal et al. CELL CYCLE
- Aging-suppressants: Cellular senescence (hyperactivation) and its pharmacologic deceleration
- (2011) Mikhail V Blagosklonny CELL CYCLE
- The CML stem cell: Evolution of the progenitor
- (2011) Scott A. Stuart et al. CELL CYCLE
- At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Rapamycin decelerates cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Genomic instability en route to and from cancer stem cells
- (2011) Linda Li et al. CELL CYCLE
- Targeting mTOR with rapamycin: One dose does not fit all
- (2011) David A. Foster et al. CELL CYCLE
- PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches
- (2011) Giovanni Ligresti et al. CELL CYCLE
- Chronic inflammation, the tumor microenvironment and carcinogenesis
- (2011) Tamas A. Gonda et al. CELL CYCLE
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- PI3K/mTORC1 activation in hamartoma syndromes: Therapeutic prospects
- (2011) Vera P. Krymskaya et al. CELL CYCLE
- Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs
- (2011) Linda S. Steelman et al. CELL CYCLE
- Growth stimulation leads to cellular senescence when the cell cycle is blocked
- (2010) Zoya N. Demidenko et al. CELL CYCLE
- Targeting prostate cancer based on signal transduction and cell cycle pathways
- (2010) John T. Lee et al. CELL CYCLE
- RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53
- (2010) Sindy Sohr et al. CELL CYCLE
- The c-Jun N-terminal kinase JNK functions upstream of Aurora B to promote entry into mitosis
- (2010) Kutluk Oktay et al. CELL CYCLE
- Aging: ROS or TOR
- (2010) Mikhail V Blagosklonny CELL CYCLE
- Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK
- (2010) Alina Felicia Nica et al. CELL CYCLE
- Basal c-Jun N-terminal kinases promote mitotic progression through histone H3 phosphorylation
- (2010) Kyunghee Lee et al. CELL CYCLE
- Enhancement of cancer chemotherapy by simultaneously altering cell cycle progression and DNA-damage defenses through global modification of the serine/threonine phospho-proteome
- (2010) Zhengping Zhuang et al. CELL CYCLE
- Specific activation of the p53 pathway by low dose actinomycin D: A new route to p53 based cyclotherapy
- (2010) Meng Ling Choong et al. CELL CYCLE
- Defining pathways that enforce cell lineage specification in early development and stem cells
- (2010) Stephen Roper et al. CELL CYCLE
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
- (2010) Stephen L. Abrams et al. CELL CYCLE
- Emerging MEK inhibitors
- (2010) James A McCubrey et al. EXPERT OPINION ON EMERGING DRUGS
- Dual Inhibition of Class IA Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin as a New Therapeutic Option for T-Cell Acute Lymphoblastic Leukemia
- (2009) F. Chiarini et al. CANCER RESEARCH
- A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal
- (2009) Federica Catalanotti et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Early Phosphatidylinositol 3-Kinase/Akt Pathway Activation Limits Poliovirus-Induced JNK-Mediated Cell Death
- (2008) A. Autret et al. JOURNAL OF VIROLOGY
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia
- (2008) E D Lagadinou et al. LEUKEMIA
- The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism
- (2008) F Chiarini et al. LEUKEMIA
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance
- (2008) J A McCubrey et al. LEUKEMIA
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
- (2008) N Misaghian et al. LEUKEMIA
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
- (2008) L S Steelman et al. LEUKEMIA
- Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors
- (2008) L S Steelman et al. ONCOGENE
- Aging, Stem Cells, and Mammalian Target of Rapamycin: A Prospect of Pharmacologic Rejuvenation of Aging Stem Cells
- (2008) Mikhail V. Blagosklonny REJUVENATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now